Current and Emerging Bladder Cancer Urinary Biomarkers

Bladder cancer continues to be one of the most common malignancies. Those who have been already diagnosed are at high risk for recurrence, especially if the pathology demonstrates high-grade disease. Diagnosis and surveillance is reliant on invasive evaluation with cystoscopy. Urinary cytology has b...

Full description

Saved in:
Bibliographic Details
Main Authors: Justin Parker, Philippe E. Spiess
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1100/tsw.2011.104
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850157083779923968
author Justin Parker
Philippe E. Spiess
author_facet Justin Parker
Philippe E. Spiess
author_sort Justin Parker
collection DOAJ
description Bladder cancer continues to be one of the most common malignancies. Those who have been already diagnosed are at high risk for recurrence, especially if the pathology demonstrates high-grade disease. Diagnosis and surveillance is reliant on invasive evaluation with cystoscopy. Urinary cytology has been used to aid in diagnosis, but its use is limited. Other assays have been developed that may aid in clinical decision making. The ultimate goal will be the development of a highly sensitive and specific urinary marker for bladder cancer. This would provide a noninvasive means of diagnosing the disease and limit the number of unnecessary cystoscopies. This article will review the currently available urinary bladder cancer markers. It will also review new and investigational urinary markers that have shown promise for future clinical use.
format Article
id doaj-art-3357d785e7334c99995f7f4e92f77175
institution OA Journals
issn 1537-744X
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-3357d785e7334c99995f7f4e92f771752025-08-20T02:24:17ZengWileyThe Scientific World Journal1537-744X2011-01-01111103111210.1100/tsw.2011.104Current and Emerging Bladder Cancer Urinary BiomarkersJustin Parker0Philippe E. Spiess1Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USADepartment of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USABladder cancer continues to be one of the most common malignancies. Those who have been already diagnosed are at high risk for recurrence, especially if the pathology demonstrates high-grade disease. Diagnosis and surveillance is reliant on invasive evaluation with cystoscopy. Urinary cytology has been used to aid in diagnosis, but its use is limited. Other assays have been developed that may aid in clinical decision making. The ultimate goal will be the development of a highly sensitive and specific urinary marker for bladder cancer. This would provide a noninvasive means of diagnosing the disease and limit the number of unnecessary cystoscopies. This article will review the currently available urinary bladder cancer markers. It will also review new and investigational urinary markers that have shown promise for future clinical use.http://dx.doi.org/10.1100/tsw.2011.104
spellingShingle Justin Parker
Philippe E. Spiess
Current and Emerging Bladder Cancer Urinary Biomarkers
The Scientific World Journal
title Current and Emerging Bladder Cancer Urinary Biomarkers
title_full Current and Emerging Bladder Cancer Urinary Biomarkers
title_fullStr Current and Emerging Bladder Cancer Urinary Biomarkers
title_full_unstemmed Current and Emerging Bladder Cancer Urinary Biomarkers
title_short Current and Emerging Bladder Cancer Urinary Biomarkers
title_sort current and emerging bladder cancer urinary biomarkers
url http://dx.doi.org/10.1100/tsw.2011.104
work_keys_str_mv AT justinparker currentandemergingbladdercancerurinarybiomarkers
AT philippeespiess currentandemergingbladdercancerurinarybiomarkers